Consist of Infection and Immune-Related Diseases expertsInnovative new drugs development company
that develops immunosuppressants,
and develops antibiotics against super bacteria to combat sepsis
DD-S052 is an innovative candidate that exterminates germs and eliminates endotoxins.
Antibiotics that treat sepsis are designed to exterminates the causative pathogens, however, the removal of endotoxins released during the apoptosis of pathogens is overlooked. Especially, the cytokine storm phenomenon, that exacerbate the morbidity of sepsis by causing necrosis in several tissues.
LPS Removal Kit
Synergistic effect by
with existing antibiotics (easier access to clinical trials)
committed to protecting the health
well-being of more people
with the best experts.
(Zipcode:05029) #304, Biomedical Science and Technology Building, Konkuk Univ., 120, Neungdong-ro, Gwangjin-gu, Seoul, Republic of Korea